This article relies largely or entirely on a single source . Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "4-D" psychedelic – news · newspapers · books · scholar · JSTOR (April 2015) |
| | |
| Clinical data | |
|---|---|
| Other names | Mescaline-D3; 4-Trideuteromethoxy-3,5-methoxyphenethylamine; 4-Trideuteromescaline |
| Routes of administration | Oral [1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 12 hours [1] |
| Identifiers | |
| |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C11H14D3NO3 |
| Molar mass | 214.278 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
4-D, also known as 4-trideuteromethoxy-3,5-methoxyphenethylamine or as 4-trideuteromescaline, is a lesser-known psychedelic drug of the scaline family. It is one of the few drugs that bears deuterium. It is a deuterated analog of mescaline. It may be prepared either as a sulfate salt or a hydrochloride salt. 4-D was first synthesized by Alexander Shulgin. In his book PiHKAL , the dosage is listed as approximately 200–400 mg for the sulfate salt, and 178–356 mg for the hydrochloride salt. 4-D lasts for approximately 12 hours. It causes closed-eye visuals, mild open-eye visuals, color distortion, and mydriasis. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-D.
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |